263 related articles for article (PubMed ID: 26446602)
1. Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.
Dicks MD; Goujon C; Pollpeter D; Betancor G; Apolonia L; Bergeron JR; Malim MH
J Virol; 2016 Jan; 90(1):22-32. PubMed ID: 26446602
[TBL] [Abstract][Full Text] [Related]
2. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.
Goujon C; Moncorgé O; Bauby H; Doyle T; Barclay WS; Malim MH
J Virol; 2014 Aug; 88(16):9017-26. PubMed ID: 24899177
[TBL] [Abstract][Full Text] [Related]
3. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
4. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.
Goujon C; Moncorgé O; Bauby H; Doyle T; Ward CC; Schaller T; Hué S; Barclay WS; Schulz R; Malim MH
Nature; 2013 Oct; 502(7472):559-62. PubMed ID: 24048477
[TBL] [Abstract][Full Text] [Related]
5. Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
Bulli L; Apolonia L; Kutzner J; Pollpeter D; Goujon C; Herold N; Schwarz SM; Giernat Y; Keppler OT; Malim MH; Schaller T
J Virol; 2016 Aug; 90(16):7469-7480. PubMed ID: 27279606
[TBL] [Abstract][Full Text] [Related]
6. MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation.
Betancor G; Bangham M; Jeon JK; Shah K; Lynham S; Jimenez-Guardeño JM; Malim MH
mBio; 2022 Aug; 13(4):e0171422. PubMed ID: 35880880
[TBL] [Abstract][Full Text] [Related]
7. Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.
Xu F; Zhao F; Zhao X; Zhang D; Liu X; Hu S; Mei S; Fan Z; Huang Y; Sun H; Wei L; Wu C; Li Q; Wang J; Cen S; Liang C; Guo F
J Biol Chem; 2020 May; 295(19):6447-6456. PubMed ID: 32217692
[TBL] [Abstract][Full Text] [Related]
8. Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction.
Dicks MDJ; Betancor G; Jimenez-Guardeño JM; Pessel-Vivares L; Apolonia L; Goujon C; Malim MH
PLoS Pathog; 2018 Nov; 14(11):e1007408. PubMed ID: 30496303
[TBL] [Abstract][Full Text] [Related]
9. Mx GTPases: dynamin-like antiviral machines of innate immunity.
Haller O; Staeheli P; Schwemmle M; Kochs G
Trends Microbiol; 2015 Mar; 23(3):154-63. PubMed ID: 25572883
[TBL] [Abstract][Full Text] [Related]
10. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
11. Host and viral determinants of Mx2 antiretroviral activity.
Busnadiego I; Kane M; Rihn SJ; Preugschas HF; Hughes J; Blanco-Melo D; Strouvelle VP; Zang TM; Willett BJ; Boutell C; Bieniasz PD; Wilson SJ
J Virol; 2014 Jul; 88(14):7738-52. PubMed ID: 24760893
[TBL] [Abstract][Full Text] [Related]
12. Porcine Mx1 Protein Inhibits Classical Swine Fever Virus Replication by Targeting Nonstructural Protein NS5B.
Zhou J; Chen J; Zhang XM; Gao ZC; Liu CC; Zhang YN; Hou JX; Li ZY; Kan L; Li WL; Zhou B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343573
[TBL] [Abstract][Full Text] [Related]
13. Host and viral determinants for MxB restriction of HIV-1 infection.
Matreyek KA; Wang W; Serrao E; Singh PK; Levin HL; Engelman A
Retrovirology; 2014 Oct; 11():90. PubMed ID: 25348155
[TBL] [Abstract][Full Text] [Related]
14. Subcellular Localization of MxB Determines Its Antiviral Potential against Influenza A Virus.
Steiner F; Pavlovic J
J Virol; 2020 Oct; 94(22):. PubMed ID: 32907985
[TBL] [Abstract][Full Text] [Related]
15. Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.
Staeheli P; Haller O
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258007
[TBL] [Abstract][Full Text] [Related]
16. MX2 is an interferon-induced inhibitor of HIV-1 infection.
Kane M; Yadav SS; Bitzegeio J; Kutluay SB; Zang T; Wilson SJ; Schoggins JW; Rice CM; Yamashita M; Hatziioannou T; Bieniasz PD
Nature; 2013 Oct; 502(7472):563-6. PubMed ID: 24121441
[TBL] [Abstract][Full Text] [Related]
17. Structural insight into HIV-1 restriction by MxB.
Fribourgh JL; Nguyen HC; Matreyek KA; Alvarez FJD; Summers BJ; Dewdney TG; Aiken C; Zhang P; Engelman A; Xiong Y
Cell Host Microbe; 2014 Nov; 16(5):627-638. PubMed ID: 25312384
[TBL] [Abstract][Full Text] [Related]
18. The Antiviral Activity of Equine Mx1 against Thogoto Virus Is Determined by the Molecular Structure of Its Viral Specificity Region.
Wagner V; Sabachvili M; Bendl E; Fuchs J; Kochs G
J Virol; 2023 Feb; 97(2):e0193822. PubMed ID: 36749070
[TBL] [Abstract][Full Text] [Related]
19. Mx Is Not Responsible for the Antiviral Activity of Interferon-α against Japanese Encephalitis Virus.
Zhou J; Wang SQ; Wei JC; Zhang XM; Gao ZC; Liu K; Ma ZY; Chen PY; Zhou B
Viruses; 2017 Jan; 9(1):. PubMed ID: 28075421
[TBL] [Abstract][Full Text] [Related]
20. Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses.
Fuchs J; Hölzer M; Schilling M; Patzina C; Schoen A; Hoenen T; Zimmer G; Marz M; Weber F; Müller MA; Kochs G
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
